title: Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction.
authors.forename: Guido
authors.initials: G
authors.lastname: Bocci
authors.forename: Antonello
authors.initials: A
authors.lastname: Di Paolo
authors.forename: Cecilia
authors.initials: C
authors.lastname: Barbara
authors.forename: Gianluca
authors.initials: G
authors.lastname: Masi
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Fornaro
authors.forename: Fotios
authors.initials: F
authors.lastname: Loupakis
authors.forename: Giacomo
authors.initials: G
authors.lastname: Allegrini
authors.forename: Alfredo
authors.initials: A
authors.lastname: Falcone
authors.forename: Mario
authors.initials: M
authors.lastname: Del Tacca
authors.forename: Romano
authors.initials: R
authors.lastname: Danesi
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000493:pharmacokinetics*; D042943:Dihydrouracil Dehydrogenase (NADP) / Q000235:genetics / Q000378:metabolism*; D005472:Fluorouracil / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000201:enzymology; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*
chemical_list: D000964:Antimetabolites, Antineoplastic; D042943:Dihydrouracil Dehydrogenase (NADP); D005472:Fluorouracil